ARCHIVES

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Hatch Committee Clears Bill Blocking OMB Micromanagement

August 15, 1986

Pooled Analysis of Two LUX-Lung Trials Shows Prolonged Survival with Afatinib

June 27, 2014

Urocidin May Provide Alternative To Cystectomy in BCG Cancers

May 27, 2011

Mammography Summit Planned For June In Milan.

March 1, 2002

Research Advocates Prepare to Face Republican-led Congress

December 19, 2014

Guest Editorial: Once Again, Hype Overshadows Data In Breast Cancer Screening Debate

February 14, 2014